Advanced search
Publication Cover
Acta Oncologica Volume 38, 1999 - Issue 8
Journal homepage
452
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Factors Influencing the Distribution of Metastases and Survival in Extensive Disease Small Cell Lung Cancer

Faruk Faruk Tas, Adnan Aydiner, Erkan Topuz, Hakan Camlica, Pinar Saip, Yesim Eralp Istanbul Universitesi, Onkoloji Enstitüsü, Capa, 34390 Istanbul, Turkey
Pages 1011-1015 | Published online: 08 Jul 2009

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hongchao Cai, Haiyong Wang, Zhenxiang Li, Jiamao Lin & Jinming Yu. (2018) The Prognostic Analysis of Different Metastatic Patterns Extensive-Stage Small-Cell Lung Cancer Patients: A Large Population-Based Study. Future Oncology 14:14, pages 1397-1407.
Read now

Articles from other publishers (33)

Suritra Bandyopadhyay, Zhenxiang Zhao, Amanda K. East, Rodrigo Tapia Hernandez, Joseph A. Forzano, Benjamin A. Shapiro, Anuj K. Yadav, Chelsea B. Swartchick & Jefferson Chan. (2024) Activity-Based Nitric Oxide-Responsive Porphyrin for Site-Selective and Nascent Cancer Ablation. ACS Applied Materials & Interfaces 16:8, pages 9680-9689.
Crossref
Yang Wang, Jared Mathai, Muhammad Alamgeer, Sagun Parakh, Eldho Paul, Paul Mitchell & Surein Arulananda. (2023) Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy. JTO Clinical and Research Reports 4:8, pages 100544.
Crossref
Veena PS, Sajeed A., Geethi MH, K. M. Jagathnath Krishna, Sivananadan CD, Arun Sankar S., Roshni S. & Lijeesh AL. (2023) Outcomes and Prognostic Factors of Extensive Stage Small Cell Lung Cancer: A Retrospective Study. South Asian Journal of Cancer.
Crossref
Shaoping Hou, Ying Fan, Xiaoyu Wang, Juan Su, Meihong Ren, Yujiao Wu, Jie Zhou, Minghui Qu, Yahong Luo & Wenyan Jiang. (2023) Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC. Academic Radiology 30:6, pages 1039-1046.
Crossref
Filiz Cimen, Sevim Düzgün, Melike Aloglu, Aysegül Sentürk & Sükran Atikcan. (2022) Correlation between tumor diameter, distant metastasis site, and survival in extensive stage small cell lung cancer. The Egyptian Journal of Bronchology 16:1.
Crossref
Zhong-Yi Zhang, An-Na Jiang, Wei Yang, Kun Yan, Wei Wu, Song Wang, Bin-Bin Jiang, Li-Qi Sun, Kun Zhao & Min-Hua Chen. (2022) Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer. Frontiers in Oncology 12.
Crossref
Hui Qin, Yu‐quan Wu, Peng Lin, Rui‐zhi Gao, Xin Li, Xin‐rong Wang, Gang Chen, Yun He & Hong Yang. (2020) Ultrasound Image–Based Radiomics. Journal of Ultrasound in Medicine 40:6, pages 1229-1244.
Crossref
Zsolt Megyesfalvi, Bernadett Tallosy, Orsolya Pipek, Janos Fillinger, Christian Lang, Thomas Klikovits, Anna Schwendenwein, Mir Alireza Hoda, Ferenc Renyi‐Vamos, Viktoria Laszlo, Melinda Rezeli, Judit Moldvay & Balazs Dome. (2021) The landscape of small cell lung cancer metastases: Organ specificity and timing. Thoracic Cancer 12:6, pages 914-923.
Crossref
Long Huang, Xiao-Liu Jiang, Hong-Bin Liang, Jian-Cheng Li, Li-Han Chin, Jian-Ping Wei, Rui-Ru Wang, Jing Cai, Qiang Xiong, Lien-Tu Wang, David S. Cram & An-Wen Liu. (2020) Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options. Molecular Medicine 26:1.
Crossref
Jia Li, Feng Liu, Haining Yu, Chenglong Zhao, Zhenxiang Li & Haiyong Wang. (2019) Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study. PeerJ 7, pages e8163.
Crossref
Linlin Gong, Liming Xu, Zhiyong Yuan, Zhongqiu Wang, Lujun Zhao & Ping Wang. (2019) Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis. Journal of Bone Oncology 19, pages 100265.
Crossref
Xiaoling Shang, Jiamao Lin, Zhenxiang Li & Haiyong Wang. (2019) Radiotherapy may improve survival of ES‑SCLC with distant metastasis only for patients with one metastatic site: A population‑based study. Oncology Letters.
Crossref
Amy Hsin‐Chieh Hsieh, Harminder Tahkar, Bogda Koczwara, Ganessan Kichenadasse, Kerri Beckmann, Christos Karapetis & Shawgi Sukumaran. (2017) Pre‐treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer. Asia-Pacific Journal of Clinical Oncology 14:2.
Crossref
Yayi He, Yan Wang, Shijia Zhang, Shengxiang Ren, Jiayu Li & Caicun Zhou. (2016) Hepatic metastasis is a poor predictive marker for erlotinib in lung adenocarcinoma. Medical Hypotheses 94, pages 20-22.
Crossref
Yijiu Ren, Chenyang Dai, Hui Zheng, Fangyu Zhou, Yunlang She, Gening Jiang, Ke Fei, Ping Yang, Dong Xie & Chang Chen. (2016) Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget 7:33, pages 53245-53253.
Crossref
Varalaxmi Bhavani Nannaka, Nihar Jani, Masooma Niazi & Dmitry Lvovsky. (2016) Acute Warfarin Toxicity as Initial Manifestation of Metastatic Liver Disease. Case Reports in Critical Care 2016, pages 1-6.
Crossref
Yu-Yu Lu, Jin-Hua Chen, Ji-An Liang, Shannon Chu, Wan-Yu Lin & Chia-Hung Kao. (2014) 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer. Nuclear Medicine Communications 35:7, pages 697-703.
Crossref
Marjan Harmsma, Bert Schutte & Frans C.S. Ramaekers. (2013) Serum markers in small cell lung cancer: Opportunities for improvement. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 255-272.
Crossref
Sha Liu, Guoli Zhang, Chunhong Li, Xuesong Chen, Shun Wang, Mingkun Wang & Li Cai. (2013) Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population. Thoracic Cancer 4:2, pages 143-152.
Crossref
KENSUKE NAKAZAWA, KOICHI KURISHIMA, TOMOHIRO TAMURA, KATSUNORI KAGOHASHI, HIROICHI ISHIKAWA, HIROAKI SATOH & NOBUYUKI HIZAWA. (2012) Specific organ metastases and survival in small cell lung cancer. Oncology Letters 4:4, pages 617-620.
Crossref
Yixia Li, Yea-Jyh Chen, Li-Jung Chang, Michael Hendryx & Juhua Luo. (2012) Clinical Biomarkers and Prognosis in Taiwanese Patients with Non-Small Cell Lung Cancer (NSCLC). Journal of Cancer Therapy 03:04, pages 412-423.
Crossref
Vikram Krishnasetty & Suzanne L. Aquino. 2011. Clinical PET-CT in Radiology. Clinical PET-CT in Radiology 163 180 .
Digant Gupta & Christopher G Lis. (2010) Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition Journal 9:1.
Crossref
S. Arinc, U. Gonlugur, O. Devran, N. Erdal, F. Ece, M. Ertugrul, D. Derince, O. Oruc & A. Hazar. (2009) Prognostic factors in patients with small cell lung carcinoma. Medical Oncology 27:2, pages 237-241.
Crossref
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti & W. K. Evans. (2007) 18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review. JNCI Journal of the National Cancer Institute 99:23, pages 1753-1767.
Crossref
Faruk Tas, Duygu Derin, Nese Guney, Hakan Camlica, Adnan Aydiner & Erkan Topuz. (2007) Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Lung Cancer 57:1, pages 79-83.
Crossref
Joachim Schneider. 2006. 1 41 .
Chad M. DeYoung & Martin J. Edelman. 2006. Tumors of the Chest. Tumors of the Chest 189 197 .
P J Ross, S Ashley, A Norton, K Priest, J S Waters, T Eisen, I E Smith & M E R O'Brien. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. British Journal of Cancer 90:10, pages 1905-1911.
Crossref
Elias Athanasakis, Eleni Mouloudi, George Prinianakis, Maria Kostaki, Maria Tzardi & Dimitrios Georgopoulos. (2003) Metastatic liver disease and fulminant hepatic failure. European Journal of Gastroenterology & Hepatology 15:11, pages 1235-1240.
Crossref
Jamie C Hey. (2003) Lung cancer in elderly patients. Clinics in Geriatric Medicine 19:1, pages 139-155.
Crossref
. 2002. TxNxM1. TxNxM1 269 365 .
Afshin Dowlati, Lori Crosby, Scot C. Remick, Vinit Makkar & Nathan Levitan. (2001) Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer — the use of complete response rate as the primary endpoint in phase II trials. Lung Cancer 32:2, pages 155-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.